Donald Trump's proposal to appoint Robert F. Kennedy Jr. as Secretary of Health and Human Services, despite Kennedy's criticisms of the pharmaceutical industry, has garnered a measured response from drug companies. Kennedy has been vocal about his views on drugmakers and vaccines in the past.